Results 251 to 253 of about 22,884 (253)

The US FDA has granted orphan drug status to Tikvah Therapeutics' sodium phenylbutyrate product,

Inpharma Weekly, 2007
openaire   +1 more source

Review of: "The orphan drug dichloroacetate reduces amyloid beta-peptide production whilst promoting non-amyloidogenic proteolysis of the amyloid precursor protein"

2021
openaire   +1 more source

HuMax-CD4 [Genmab A/S] has received orphan drug status by the European Agency for the Evaluation of Medicinal Products

Inpharma Weekly, 2004
openaire   +1 more source